Mutational Scanning Symposium

Myllia will be joining the Mutational Scanning Symposium hosted by the Wellcome Sanger Institute in Hinxton, Cambridge!

Reach out to our colleague Lukas Badertscher, Director of R&D, to discuss your functional genomics projects and potential CRISPR screening questions.

We will be happy to talk about synthetic lethality CRISPR screens and gene regulatory networks linked to disease mechanisms and immuno-oncology research.